Bharat Biotech Trashes Reports Claiming It Has Submitted Covaxin’s Phase 3 Trial Data to WHO

Bharat Biotech, COVAXIN maker, on Thursday, trashed the media reports claiming that the company has submitted the Phase-3 date of the vaccine to the World Health Organisation (WHO).

Written by: India.com News Desk Edited by: Victor Dasgupta

Published: June 17, 2021, 7:47 PM IST

Share

Share Article

• Facebook
• WhatsApp
• X
• Email
• Telegram
• Linkedin

https://www.india.com/news/india/bharat-biotech-trashes-reports-claiming-it-has-submitted-covaxins-phase-3-trial-data-to-who-4748011/ Copy

Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new Delta variant.

New Delhi: Bharat Biotech, COVAXIN maker, on Thursday, trashed the media reports claiming that the company has submitted the Phase-3 date of the vaccine to the World Health Organisation (WHO). Earlier, news reports claimed that India’s indigenous COVID vaccine ‘Covaxin’ manufacturer Bharat Biotech has submitted its phase-3 clinical trial results to the World Health Organization (WHO) for clearance on Wednesday.

It also added that the Hyderabad-based Bharat Biotech’s pre-submission meeting has been scheduled on June 23 for evaluation of the WHO’s Emergency Use Listing (EUL) of its indigenous COVID-19 vaccine Covaxin.